v3.26.1
Net financial results (Details) - BRL (R$)
R$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Financial expenses [Abstract]    
Interest on loans, financing and debentures (1) R$ (1,401,182) R$ (1,360,125)
Premium expenses on early settlements 129,047
Amortization of transaction costs (58,457) (31,923)
Interest expenses on lease liabilities (3) (113,211) (116,258)
Other (103,034) (131,779)
Financial expenses (1,804,931) (1,640,085)
Financial income [Abstract]    
Cash and cash equivalents and marketable securities 464,425 348,428
Other 21,588 90,425
Financial income 486,013 438,853
Results from derivative financial instruments [Abstract]    
Income 3,477,696 4,224,351
Expenses (452,097) (531,192)
Derivative financial instruments, net 3,025,599 3,693,159
Monetary and exchange rate variations, net [Abstract]    
Exchange rate variations on loans, financing and debentures 3,419,196 5,702,984
Leases 119,661 199,040
Other assets and liabilities (4) (629,102) (697,738)
Monetary and exchange variations, net 2,909,755 5,204,286
Net financial result 4,616,436 7,696,213
Interest costs capitalised 24,929 52,753
Reclassification to biological assets 64,577 66,200
Disclosure of detailed information about biological assets [line items]    
Reclassification to biological assets R$ 64,577 R$ 66,200